Results 11 to 20 of about 58,007 (253)
Frontiers in Medicine, 2022 Introduction: Despite intensive research, reliable blood-derived parameters to detect clinically significant portal hypertension (CSPH) in patients with cirrhosis are lacking.
Lukas Sturm +14 more
doaj +1 more source
NON-INVASIVE TOOLS TO ASSESS THE RISK OF VARICES-NEEDING-TREATMENT IN CIRRHOSIS SECONDARY TO HCV
Pakistan Armed Forces Medical Journal, 2021 Objective: To assess the non-invasive biomarkers of fibrosis for predicting varices-needing-treatment in patients with cirrhosis secondary to chronic-hepatitis-C. Study Design: Cross sectional comparative study.
Laima Alam, Farrukh Saeed
doaj +3 more sources
Pakistan Armed Forces Medical Journal, 2021 Objective: To determine the spectrum of findings in patients presenting for upper gastrointestinal (UGI) endoscopy and investigate role of age and gender. Study Design: Cross-sectional study.
Fayyaz Hassan +3 more
doaj +1 more source
Clinical and Endoscopic Profile of Upper Gastrointestinal Bleed: A Cross-sectional Study from a Tertiary Care Hospital in Southern India [PDF]
Journal of Clinical and Diagnostic Research, 2021 ntroduction: Acute Upper Gastrointestinal (UGI) bleed is a common potentially life threatening emergency. The aetiological profile of bleed and prognosis varies according to geographical region and availability of endoscopic facilities.
Manju Surendran, K Sunil Kumar
doaj +1 more source
Validation of the EVendo score for the prediction of varices in cirrhotic patients
The Saudi Journal of Gastroenterology, 2022 Background: Screening endoscopy for varices may be deferred when the calculated EVendo score is ≤3.90. This novel score has not been validated in an external cohort.
Khalid Alswat +6 more
doaj +1 more source
JGH Open, 2021 Background and Aim Gastric antral vascular ectasia (GAVE) is observed in patients with liver cirrhosis and portal hypertension. The exact pathophysiologic mechanism that underlies this condition is unknown.
Magdy Fouad +5 more
doaj +1 more source
Frontiers in Oncology, 2022 Recently, a combined regimen of atezolizumab and bevacizumab (AB) treatment has been approved as a first-line treatment in patients with advanced hepatocellular carcinoma (HCC), contributing to prolonged survival.
Hiroyuki Suzuki +12 more
doaj +1 more source
JGH Open, 2021 Background and Aim Acute variceal bleeding (AVB) is a serious complication associated with high mortality. The aim of our study was to investigate mortality predictors and to develop a new simplified prognostic model among cirrhotic patients with AVB ...
Sakkarin Chirapongsathorn +2 more
doaj +1 more source
Insights into pelvic venous disorders
Frontiers in Cardiovascular Medicine, 2023 Pelvic venous disorders (PeVD), sometimes referred to as pelvic congestion syndrome (PCS), widely impact affected patients–mainly young women’s quality of life, causing puzzling, uncomfortable symptoms sometimes requiring months or years to get an ...
Kiara Rezaei-Kalantari +3 more
doaj +1 more source
Indian Pediatrics Case Reports, 2023 Background: Umbilical vein catheterization is a routine procedure in neonatal intensive care units. This invasive procedure, though easy and useful, can result in disastrous complications.
Surbhi Latawa +3 more
doaj +1 more source